Can You Really Boost Brain NAD+? What New Human Studies Suggest

If you spend five minutes in longevity Twitter you’d think everyone is “raising NAD+” and unlocking infinite energy. The reality is both more interesting and more grounded: we now have human studies that can actually measure NAD+ in the brain, show when (and where) it goes up, and outline what’s still uncertain.

Here’s a clear, hype-free guide to what NAD+ is, how to raise it, what the best evidence says, and how to use that evidence safely.

---

NAD+ in one minute

• What it is: A core cellular coenzyme that powers energy production (redox reactions) and fuels DNA repair (PARPs) and longevity-linked enzymes (sirtuins).
• Why it matters: Levels of NAD+ tend to decline with age in multiple tissues, including the brain and muscle.
• How we measure it: High-field MRI spectroscopy (7-Tesla ^1H-MRS and ^31P-MRS) can quantify cerebral NAD+ in living humans, and those tools show age-related declines. ClinicalTrials+1

---

Can we raise brain NAD+ in humans?

Short answer: Yes, at least in specific contexts.

• In the NADPARK phase-1 study in people with Parkinson’s disease, oral nicotinamide riboside (NR) increased cerebral NAD as measured by ^31P-MRS over 4 weeks. This is the strongest direct human evidence to date that a precursor can lift brain NAD in vivo. Nature

Why this matters: many trials show NAD+ or its breakdown products rise in blood, but blood ≠ brain. MRS lets us see inside the skull and confirm target engagement.

---

What about NMN (and MIB-626)?

• Blood evidence: Multiple trials of β-NMN (including MIB-626, a microcrystalline NMN) in middle-aged/older adults report dose-related increases in circulating NAD metabolites and generally good short-term tolerability. (Several are preprints or early reports.) MedRxiv+2ResearchGate+2
• Brain evidence: Ongoing studies are testing whether NMN/NR can raise brain NAD+ in healthy adults; early work has established reliable brain-NAD measurement methods at 7T. We’re still waiting for large, placebo-controlled, peer-reviewed results in healthy brains. ClinicalTrials

Bottom line: We have direct brain data for NR (NADPARK, in PD). For NMN, we have strong blood data and active investigations; definitive brain-MRS results in healthy cohorts are still limited.

---

What benefits should you expect?

Think of NAD+ as an enabler, not a magic bullet. When NAD+ rises:

• Mitochondrial efficiency and cellular energy metabolism can improve.
• DNA repair and stress-response pathways (PARPs, sirtuins) have more “fuel.” In specific patient groups (e.g., Parkinson’s), raising brain NAD has been demonstrated; whether that translates to clinical outcomes requires larger phase-2/3 trials. Nature

For healthy adults, trials with NMN/NR commonly report biomarker shifts (NAD metabolome), with mixed results on performance or body composition endpoints so far. Expect subtle effects rather than dramatic changes—and prioritize fundamentals (sleep, protein, resistance training, fiber, sunlight).

---

Choosing a strategy: food, habits, or supplements?

1) Foundations that support NAD+

• Resistance & zone-2 training, circadian regularity, and caloric moderation can all support NAD+ homeostasis. (They also improve mitochondrial health independent of supplements.)
• Protein & micronutrients: riboflavin, niacin equivalents, tryptophan, magnesium, and polyphenols support NAD+ pathways and mitochondrial enzymes.

2) NAD+ precursors (what we actually know)

Practical note: Bioavailability and tissue targeting may differ by precursor and dose; some data suggest NR and NMN can be interconverted in the gut/enterocytes before cellular uptake. Human brain targeting is where MRS studies are most informative—and still relatively few. ClinicalTrials

---

How to use this safely

• Start low, re-check basics: If you choose to try a precursor, stack it on top of sleep, training, and protein.
• Dosing: Many human studies used 250–1000 mg/day ranges for NR or NMN for weeks. There isn’t a universally “optimal” dose, and more is not always better. (Discuss with your clinician, especially if you have cancer history or are on chemo/immune therapy.)
• Cycle & monitor: Consider 8–12 week blocks with breaks; track how you feel, training quality, BP, lipids, glucose, and sleep.
• Quality matters: Choose third-party-tested products with transparent labels.
• Regulatory status: The regulatory landscape for NMN can change and varies by country; check current local guidance if you plan to purchase NMN products. A 2023 scientific review summarizes the state of human NMN trials and open questions. ClinicalTrials

---

Smart stacks (if you supplement)

Evidence for “synergy” is still early. If you experiment, keep it minimal and measurable:

1. NR or NMN (single agent) → establish tolerance and any signal.
2. Add exercise (especially resistance + zone-2) → likely the highest-ROI “stack” for mitochondrial function.
3. Optional: polyphenols (e.g., resveratrol) are often paired mechanistically but human synergy data are limited; don’t out-supplement sleep.

Keep supplements separate from training sessions at first so you can attribute effects.

---

Who should not experiment casually

• Active cancer or a strong personal history of cancer (NAD+ fuels repair and proliferation pathways; talk to your oncologist).
• Pregnancy/breastfeeding (insufficient safety data).
• On chemo, immunotherapy, or PARP inhibitors (possible interactions—must clear with your care team).

When in doubt, get medical advice and start with lifestyle levers.

---

The takeaways

• Brain NAD can be raised in humans—shown most clearly with NR in PD patients using MRS. Nature
• Blood NAD goes up reliably with both NR and NMN; translating that to meaningful performance or longevity outcomes in healthy adults is an open question. MedRxiv+1
• The safest, highest-yield “stack” is still sleep + training + protein + daylight. Use precursors as an adjunct, not a substitute.
• Watch this space: more brain-MRS trials in healthy cohorts are underway, which should finally tell us how much, how fast, and for whom cerebral NAD+ can be elevated. SpringerLink